An introduction to cerebral visual impairment.

Utilizing artificial intelligence may provide feasibility assessments, data-driven protocol design, and cost reduction opportunities.

Cofounders Camille F. Cohen, OD, FAAO, and Janis James, OD, FAAO discuss what the organization has been up to at the National Optometric Association Convention.

Study investigators conducted a case-control study to investigate the corneal topography parameters and biomechanics in patients with alopecia areata.

Sherrol A Reynolds, OD, speaks on event highlights from this year's NOA convention in Philadelphia, Pennsylvania.

A. Philip Aitsebaomo, OD, PhD, informs eye care providers to get comfortable with handling prosthetics and stay educated to find the best fit for patients.

The primary endpoint will be pain improvement as measured by visual analogue scale (VAS) compared to placebo.

Catch up on what happened in optometry during the week of July 8-July 12.

Educating parents of pediatric patients starts with getting staff on the same page.

Prescriptions with semaglutide (Wegovy, Ozempic, Novo Nordisk) are FDA approved to treat obesity and type 2 diabetes, respectively.

Ambient listening and transcription provide promising impact on the patient care experience.

The UOA offers networking opportunities with over 140,000 spectacle and contact lens opticians.

FYSX is the first non-pharmacological, non-surgical treatment designed to lower IOP for glaucoma patients, according to a news release.

What to know about evolving guidelines and potential medicolegal risks.

Pediatric TINU syndrome is rare, but responds well to treatment.

The survey found that most participants may not know that their symptoms could be associated with eye dryness, including redness, fluctuating vision, a scratch, gritty, tired, or heavy feeling in the eye, or overall eye irritation.

Catch up on what happened in optometry during the week of July 1-July 5.

According to Genentech, faricimab-svoa is the first and only syringe that is prefilled with an FDA-approved bispecific antibody to treat wet AMD, DME and RVO.

Belkin Vision is the developer of Vision Eagle direct selective laser trabeculoplasty technology.

Aiming to address long-standing challenges without sacrificing accuracy.